Martin F Lavin Selected Research

Martin F Lavin Research Topics

Disease

32	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 08/2002
21	Neoplasms (Cancer) 01/2022 - 08/2002
11	Genomic Instability 01/2022 - 08/2002
11	Inborn Genetic Diseases (Disease, Hereditary) 05/2020 - 12/2002
10	Prostatic Neoplasms (Prostate Cancer) 12/2017 - 05/2005
8	Ataxia (Dyssynergia) 01/2015 - 06/2007
7	Pulmonary Fibrosis (Fibrosing Alveolitis) 08/2022 - 01/2018
7	Inflammation (Inflammations) 03/2022 - 01/2013
7	Apraxias (Dyspraxia) 06/2019 - 06/2007
5	Fibrosis (Cirrhosis) 02/2021 - 01/2018
4	Hemorrhage 08/2022 - 07/2006
4	Thrombosis (Thrombus) 08/2022 - 07/2006
4	Silicosis 03/2022 - 01/2018
4	Lung Diseases (Lung Disease) 02/2021 - 11/2018
4	autosomal recessive 1 Spinocerebellar ataxia 06/2019 - 05/2006
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2010 - 09/2006
3	Atrophy 06/2019 - 01/2013
3	Infections 01/2019 - 05/2009
2	Wounds and Injuries (Trauma) 08/2022 - 03/2012
2	Neuroinflammatory Diseases 12/2021 - 01/2017
2	Lung Injury 04/2021 - 02/2021
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 09/2012
2	Chromosome Aberrations (Chromosome Abnormalities) 10/2015 - 08/2002
2	Glioma (Gliomas) 09/2012 - 03/2005
2	Breast Neoplasms (Breast Cancer) 06/2010 - 01/2002
2	Chromosomal Instability (Chromosome Stability) 05/2009 - 01/2002
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 07/2008 - 05/2006
2	Starvation 10/2003 - 01/2003
1	Cockayne Syndrome (Syndrome, Cockayne) 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2020
1	Rheumatoid Arthritis 10/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2020
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2020
1	Asthma (Bronchial Asthma) 12/2019
1	Occupational Asthma 12/2019
1	Oculomotor Nerve Diseases (Oculomotor Nerve Palsy) 06/2019

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 08/2022 - 08/2002
28	DNA (Deoxyribonucleic Acid)IBA 05/2020 - 08/2002
9	Phosphotransferases (Kinase)IBA 12/2019 - 01/2002
8	Ataxia Telangiectasia Mutated ProteinsIBA 01/2017 - 01/2003
7	Silicon Dioxide (Silica)FDA LinkGeneric 08/2022 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 08/2022 - 05/2005
6	Protein Kinases (Protein Kinase)IBA 01/2022 - 08/2004
4	VenomsIBA 10/2020 - 02/2006
4	ChromatinIBA 01/2015 - 07/2008
4	Complementary DNA (cDNA)IBA 05/2004 - 01/2002
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2013
3	A-Form DNA (A-DNA)IBA 05/2020 - 11/2009
3	AntioxidantsIBA 01/2020 - 09/2006
3	CytokinesIBA 12/2019 - 01/2013
3	AntigensIBA 09/2016 - 01/2009
3	RNA (Ribonucleic Acid)IBA 09/2016 - 01/2014
3	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 09/2015 - 06/2007
2	Snake Venoms (Snake Venom)IBA 08/2022 - 02/2006
2	textilininIBA 08/2022 - 04/2009
2	Particulate MatterIBA 03/2022 - 03/2019
2	InflammasomesIBA 03/2022 - 01/2019
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2016
2	Messenger RNA (mRNA)IBA 12/2019 - 05/2005
2	SuspensionsIBA 11/2018 - 01/2018
2	A-factor (Streptomyces)IBA 03/2016 - 03/2012
2	MicroRNAs (MicroRNA)IBA 04/2015 - 08/2014
2	hepsinIBA 04/2015 - 05/2005
2	Histones (Histone)IBA 01/2015 - 02/2012
2	Fibrinolysin FDA Link 01/2013 - 04/2009
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2010 - 11/2004
2	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2009 - 07/2006
2	Aprotinin (Trasylol)FDA Link 04/2009 - 07/2006
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2004 - 10/2003
1	SiliconIBA 08/2022
1	Hemostatics (Antihemorrhagics)IBA 08/2022
1	Warfarin (Coumadin)FDA LinkGeneric 08/2022
1	HydrogelsIBA 08/2022
1	ecarinIBA 08/2022
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 08/2022
1	Competitive Endogenous RNAIBA 03/2022
1	EndonucleasesIBA 01/2022
1	Interferon Type IIBA 12/2021
1	Hydroxyproline (4 Hydroxyproline)IBA 04/2021
1	hesperetinIBA 04/2021
1	Emodin (Archin)IBA 02/2021
1	AnthraquinonesIBA 02/2021
1	Benzene (Benzole)IBA 01/2020
1	IonophoresIBA 01/2020
1	salinomycinIBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Thymic Stromal LymphopoietinIBA 12/2019
1	Polyurethanes (Polyurethane)IBA 12/2019
1	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 12/2019
1	Interleukin-4 (Interleukin 4)IBA 12/2019
1	Interleukin-17 (Interleukin 17)IBA 12/2019
1	Neutralizing AntibodiesIBA 12/2019
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 12/2019
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 06/2019

Therapy/Procedure

7	Therapeutics 01/2022 - 09/2006
4	Radiotherapy 01/2020 - 06/2010
3	Transplantation 03/2019 - 01/2018
3	Prostatectomy (Retropubic Prostatectomy) 10/2016 - 05/2012
2	Ligation 03/2010 - 11/2009
1	Aftercare (After-Treatment) 12/2019